Referenzen

  1. Schupp JC, ..., Jonigk DD,…. Alveolar Vascular Remodeling in Nonspecific Interstitial Pneumonia: Replacement of Normal Lung Capillaries with COL15A1 Positive Endothelial Cells. Am J Respir Crit Care Med. 2023;208(7):819-822.
     
  2. Verleden S, …, Länger FP, …, Jonigk D. From macroscopy to ultrastructure: an integrative approach to pulmonary pathology. Front Med (Lausanne). 2022;9:859337.
     
  3. Kamp JC, …, Länger F, …, Jonigk DD. Time-dependent molecular motifs of pulmonary fibrogenesis in COVID-19. Int J Mol Sci. 2022;23(3):1583.
     
  4. Ackermann M, …, Länger FP, …, Jonigk DD. The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodeling. EBioMedicine. 2022;14(9):2058.
     
  5. Kamp JC, …, Länger F, …, Jonigk DD. Comparative characterization of fibroblastic foci in pulmonary fibrogenesis. Cells. 2022;11(4):664.
     
  6. Jaeger B, …, Jonigk D, ….Wygrecka M, Klatt D, Schambach A, Kaminski N, Prasse A. Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis. Nat Commun. 2022;13(1):5637.
     
  7. Ackermann M, …, Länger F, …, Jonigk D. The bronchial circulation in COVID-19 pneumonia. Am J Respir Crit Care Med. Am J Respir Crit Care Med. 2022;205(1):121-125.
     
  8. Walsh C, …, Jonigk D*, Ackermann M*, Lee PD*. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography. Nat Methods. 2021;18(12):1532-1541. *Joint corresponding authors
     
  9. Schipke J, …, Jonigk D,... Lipofibroblasts in structurally normal, fibrotic and emphysematous human lungs. Am J Respir Crit Care Med. 2021;204(2):227-230.
     
  10. Hagner M, ….., Jonigk D, …. IL- 17A from innate and adaptive lyphmocytes contributes to inflammation and damage in cystic fibrosis lung disease. Eur Respir J. 2021;57(6):1900716.
     
  11. Ackermann M, ….., Länger F, …, Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis and Angiogenesis in COVID-19. N Engl J Med. 2020;383(2):120-128.
     
  12. Ackermann M, …, Jonigk D. Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases. Eur Respir J. 2020;55(3):1900933.
     
  13. Jonigk D, …, Länger F. Morphological and molecular motifs of fibrosing pulmonary injury patterns. J Pathol Clin Res. 2019;5(4):256-271.
     
  14. Kordes A, …, Jonigk D,…. Genetically diverse Pseudomonas aeruginosa populations display similar transciptomic profiles in a cystic fibrosis explanted lung. Nat Commun. 2019;10(1):3397.
     
  15. Ackermann M, …, Jonigk D. Plexiform vasculopathy in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2017;196(8):e48-e51.
     
  16. Jonigk D, …, Länger F. Comparative Analysis of Morphological and Molecular Motifs in Bronchiolitis Obliterans and Alveolar Fibroelastosis after Lung and Stem Cell Transplantation. J Pathol Clin Res 2016;3(1): 17-28.
     
  17. Jonigk D, …, Länger F. Molecular Profiling in Lung Biopsies of Human Pulmonary Allografts to Predict Chronic Lung Allograft Dysfunction. Am J Pathol 2015;185(12): 3178-88.
     
  18. Bockmeyer CL, …, Länger F, Jonigk D. Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant 2012;31(7):764-72.
     
  19. Jonigk D, …, Länger F. Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol 2011;179(1):167-79. *shared first author
     
  20. Jonigk D,… , Länger F. Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs. Am J Pathol 2011;179(1):167-79.
     

  21. Ackermann M, …, Länger F, …, Jonigk DD. The role of vasculature and angiogenesis in respiratory diseases. Angiogenesis. 2024;27(3):293-310. 

  22. Windrich J, …, Länger F, …, Kratz CP. RAS-MAPK Pathway Mutations in Congenital Pulmonary Airway Malformations. Am J Respir Crit Care Med. 2024;209(10):1266-1268.

  23. Malapelle U, …, Länger F, …, Rolfo C. Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer. Br J Cancer. 2024;131(2):212-219. 

  24. Schütz K, Länger F, …, Schwerk N The Exception Proves the Rule: First Case of Tuberous Sclerosis-Related Pulmonary Lymphangioleiomyomatosis (LAM) in a Male Adolescent. Klin Padiatr 2023;235(2):103-106.

  25. Frost N, …, Länger F, …, Reck M Lung Cancer in Germany. J Thorac Oncol 2022;17(6):742-750

  26. Thiemann I, …, Länger F, …, Nüßlein T. Complete Tracheal Ring Deformity, Recurrent Pneumothoraces and Pleuropulmonary Blastoma in a Child: Coincidence or Common Genetic Cause? Klin Padiatr. 2022;234(5):311-313. 

  27. Stenzinger A, …, Länger F, …, Seufferlein TTW. Diagnosis and therapy of tumors with NTRK gene fusion. Pathologe 2021;42(1):103-115